Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · S

S. 1208 (107th)

Ecstasy Prevention Act of 2001

referredUnited States· United States Congress· EN

Introduced

19 July 2001

Last action

19 July 2001 · Introduced

Status

Read twice and referred to the Committee on the Judiciary.

Sponsors

Sen. Graham, Bob [D-FL], Sen. Grassley, Chuck [R-IA], Sen. Lieberman, Joseph I. [ID-CT], Sen. Durbin, Richard J. [D-IL], Sen. Landrieu, Mary L. [D-LA], Sen. Clinton, Hillary Rodham [D-NY], Sen. Schumer, Charles E. [D-NY], Sen. Akaka, Daniel K. [D-HI], Sen. Bunning, Jim [R-KY], Sen. Torricelli, Robert G. [D-NJ], Sen. Carnahan, Jean [D-MO]

Subjects

Healthcare

Source updated

10 August 2026

Healthcare

Summary

Ecstasy Prevention Act of 2001 - Amends the Public Health Service Act to require the Administrator of the Substance Abuse and Mental Health Services Administration to give priority in the award of certain grants to States on a pass-through basis to communities that have taken measures to combat club drug use, including passing ordinances restricting rave clubs, increasing law enforcement on Ecstasy (3,4-methylenedioxy methamphetamine or MDMA), and seizing lands under nuisance abatement laws to make new restrictions on an establishment's use. Requires the Director of the Office of National Drug Control Policy to: (1) use amounts available under this Act to combat the trafficking of Ecstasy in designated high intensity drug trafficking areas; and (2) ensure that the national media campaign under the Drug-Free Media Campaign Act of 1998 addresses the reduction and prevention of abuse of Ecstasy and club and emerging drugs among young people in the United States. Provides for: (1) funding for an Ecstasy drug test which would meet Federal workplace standards; and (2) a mandatory research study by the Director of the National Institute on Drug Abuse that evaluates the effects that Ecstasy use can have on an individual's health. Requires the Director of the Office of National Drug Control Policy to establish an interagency Task Force on Ecstasy/MDMA and Emerging Club Drugs.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 19 July 2001

    Introduced

    Sponsor introductory remarks on measure. (CR S7966-7967)

    Source: IntroReferral

  2. 19 July 2001

    Introduced

    Read twice and referred to the Committee on the Judiciary.

    Source: IntroReferral

  3. 19 July 2001

    Introduced

    Introduced in Senate

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in Senate (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate (text)

    Introduced in Senate · EN · 19 July 2001

    ViewDownloadOpen at official source

  • Introduced in Senate (PDF)

    Introduced in Senate · EN · 19 July 2001

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate

    summary · EN · 19 July 2001

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.